DDR1 was significantly elevated in advanced HCC patient samples, while ANKRD17-overexpression was also reported in advanced stage HCC samples and, importantly, in lung metastases compared to primary liver tumors (Figure S5). Here, ANKRD17 is linked to hepatocellular carcinoma.